Literature DB >> 16426061

New scoring functions for virtual screening from molecular dynamics simulations with a quantum-refined force-field (QRFF-MD). Application to cyclin-dependent kinase 2.

Ph Ferrara1, A Curioni, E Vangrevelinghe, T Meyer, T Mordasini, W Andreoni, P Acklin, E Jacoby.   

Abstract

A recently introduced new methodology based on ultrashort (50-100 ps) molecular dynamics simulations with a quantum-refined force-field (QRFF-MD) is here evaluated in its ability both to predict protein-ligand binding affinities and to discriminate active compounds from inactive ones. Physically based scoring functions are derived from this approach, and their performance is compared to that of several standard knowledge-based scoring functions. About 40 inhibitors of cyclin-dependent kinase 2 (CDK2) representing a broad chemical diversity were considered. The QRFF-MD method achieves a correlation coefficient, R(2), of 0.55, which is significantly better than that obtained by a number of traditional approaches in virtual screening but only slightly better than that obtained by consensus scoring (R(2) = 0.50). Compounds from the Available Chemical Directory, along with the known active compounds, were docked into the ATP binding site of CDK2 using the program Glide, and the 650 ligands from the top scored poses were considered for a QRFF-MD analysis. Combined with structural information extracted from the simulations, the QRFF-MD methodology results in similar enrichment of known actives compared to consensus scoring. Moreover, a new scoring function is introduced that combines a QRFF-MD based scoring function with consensus scoring, which results in substantial improvement on the enrichment profile.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16426061     DOI: 10.1021/ci050289+

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  5 in total

1.  Transferable scoring function based on semiempirical quantum mechanical PM6-DH2 method: CDK2 with 15 structurally diverse inhibitors.

Authors:  Petr Dobeš; Jindřich Fanfrlík; Jan Rezáč; Michal Otyepka; Pavel Hobza
Journal:  J Comput Aided Mol Des       Date:  2011-02-01       Impact factor: 3.686

2.  Application of a novel in silico high-throughput screen to identify selective inhibitors for protein-protein interactions.

Authors:  Catherine Joce; Joshua A Stahl; Mitesh Shridhar; Mark R Hutchinson; Linda R Watkins; Peter O Fedichev; Hang Yin
Journal:  Bioorg Med Chem Lett       Date:  2010-07-30       Impact factor: 2.823

3.  Transcription Factor DLX5 As a New Target for Promising Antitumor Agents.

Authors:  R A Timakhov; P O Fedichev; A A Vinnik; J R Testa; O O Favorova
Journal:  Acta Naturae       Date:  2011-07       Impact factor: 1.845

4.  Enrichment of chemical libraries docked to protein conformational ensembles and application to aldehyde dehydrogenase 2.

Authors:  Bo Wang; Cameron D Buchman; Liwei Li; Thomas D Hurley; Samy O Meroueh
Journal:  J Chem Inf Model       Date:  2014-06-30       Impact factor: 4.956

5.  High-performance drug discovery: computational screening by combining docking and molecular dynamics simulations.

Authors:  Noriaki Okimoto; Noriyuki Futatsugi; Hideyoshi Fuji; Atsushi Suenaga; Gentaro Morimoto; Ryoko Yanai; Yousuke Ohno; Tetsu Narumi; Makoto Taiji
Journal:  PLoS Comput Biol       Date:  2009-10-09       Impact factor: 4.475

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.